Pacific Immunology

Executive Summary

Pacific Immunology, founded in 1980 and based in San Diego, is a global leader in custom antibody production services with over 54 years of experience. The company specializes in generating high-affinity, epitope-specific antibodies backed by industry-leading titer guarantees. Its comprehensive service packages streamline ordering, reduce costs, and support research programs worldwide. As a private entity with no disclosed financials, Pacific Immunology operates in the competitive antibodies market, leveraging its long-standing expertise to serve academic, biotech, and pharmaceutical clients. The company's stable, service-oriented business model provides consistent revenue but limited visibility into growth catalysts beyond organic expansion.

Upcoming Catalysts (preview)

• Q3 2026Expansion of production capacity60% success
• TBDStrategic partnership with large biotech or pharma40% success
• Q4 2026Launch of AI-driven antibody discovery platform30% success